Results
|
|
1.
|
Plasma Ceramide Species Are Associated with Diabetes Risk in Participants of the Strong Heart Study. MedStar authors:
- Howard, Barbara V
- Umans, Jason G
Year: 2020
Citation: - Journal of Nutrition. 150(5):1214-1222, 2020 05 01.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Fretts AM, Hoofnagle A, Howard BV, Jensen PN, King IB, Lemaitre RN, McKnight B, Siscovick DS, Sitlani C, Sotoodehnia N, Umans J, Yu C
|
|
|
2.
|
Novel metabolic markers for the risk of diabetes development in American Indians. MedStar authors:
Citation: - Diabetes Care. 38(2):220-7, 2015 Feb.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
All authors: - He J, Howard BV, Hyun N, Jones D, Lee ET, Tran VT, Uppal K, Yu T, Zeng D, Zhao J, Zhu Y
|
|
|
3.
|
Steroid Sex Hormones, Sex Hormone-Binding Globulin, and Diabetes Incidence in the Diabetes Prevention Program. MedStar authors:
Year: 2015
Citation: - Journal of Clinical Endocrinology & Metabolism. 100(10):3778-86, 2015 Oct.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, P.H.S.
All authors: - Aroda VR, Barrett-Connor E, Christophi CA, Diabetes Prevention Program, Edelstein SE, Florez JC, Goldberg RB, Kahn SE, Kim C, Knowler WC, Labrie F, Mather KJ
|
|
|
4.
|
A prospective study of leukocyte telomere length and risk of type 2 diabetes in postmenopausal women. MedStar authors:
Citation: - Diabetes. 61(11):2998-3004, 2012 Nov.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
All authors: - Chen BH, Chen Y, Curb JD, Howard BV, Kang M, Liu S, Lu X, Manson JE, Margolis KL, Phillips LS, Song Y, Stefanick ML, Tinker LF, You NC
|
|
|
5.
|
Plasma epoxyeicosatrienoic acids and dihydroxyeicosatrieonic acids, insulin, glucose and risk of diabetes: The strong heart study. MedStar authors:
- Howard, Barbara V
- Umans, Jason G
Year: 2021
Citation: - EBioMedicine. 66:103279, 2021 Apr.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Denham J, Fretts AM, Gharib SA, Howard BV, Jensen PN, King IB, Lemaitre RN, McKnight B, Psaty BM, Siscovick DS, Sitlani CM, Sotoodehnia N, Totah RA, Umans JG, Zeigler M
|
|
|
6.
|
Regression from prediabetes to normal glucose regulation is associated with reduction in cardiovascular risk: results from the Diabetes Prevention Program outcomes study. MedStar authors:
Year: 2014
Citation: - Diabetes Care. 37(9):2622-31, 2014 Sep.
All authors: - Diabetes Prevention Program Research Group, Goldberg RB, Hamman RF, Horton E, Kitabchi A, Larkin M, Mather KJ, Montez MG, Orchard TJ, Perreault L, Temprosa M, Thayer D
|
|
|
7.
|
Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study). MedStar authors:
- Fatemi, Omid
- Yuriditsky, Eugene
Citation: - American Journal of Cardiology. 114(8):1217-22, 2014 Oct 15.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
All authors: - Basile J, Bigger T, Cushman W, Fatemi O, Goff D, Morgan T, Papademetriou V, Soliman EZ, Thomas A, Tsachris D, Tsioufis C, Yuriditsky E
|
|
|
8.
|
Target organ damage and incident type 2 diabetes mellitus: the Strong Heart Study. MedStar authors:
Year: 2017
Citation: - Cardiovascular Diabetology. 16(1):64, 2017 05 12
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Best LG, de Simone G, Devereux RB, Howard BV, Izzo R, Lee ET, Mancusi C, Roman MJ, Wang W, Yeh F
|
|
|
9.
|
Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factors. MedStar authors:
Year: 2013
Citation: - Arteriosclerosis, Thrombosis & Vascular Biology. 33(2):393-9, 2013 Feb.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, Non-P.H.S.
All authors: - Banerji M, Bray GA, Buchanan TA, Clement SC, DeFronzo RA, Henry RR, Hodis HN, Kitabchi AE, Mack WJ, Mudaliar S, Musi N, Ratner RE, Reaven PD, Saremi A, Schwenke DC, Stentz FB, Tripathy D
|
